Skip to main content
. Author manuscript; available in PMC: 2013 May 3.
Published in final edited form as: Urology. 2010 Sep;76(3):553–557. doi: 10.1016/j.urology.2010.02.069

Table 1. Clinical and pathologic features of 14,052 men undergoing RP at Johns Hopkins Hospital from 1983 to 2006 stratified by Charlson Comorbidity Index.

Entire Cohort n = 14,052 CCI = 0 n = 12,117 CCI = 1 n = 1,736 CCI ≥ 2 n = 199 P Value
Mean age ± (SD) 58.1 (± 6.5) 58.0 (± 6.5) 58.9 (± 6.4) 59.9 (± 5.7) <.001
Median follow-up (IQR) 7.6 (4.3-11.5) 7.7 (4.4-11.6) 6.8 (3.6-10.7) 5.5 (3.1-9.7) <.001
Biopsy Gleason score .004
 ≤6 10,701 (76%) 9290 (77%) 1272 (73%) 1393 (70%)
 7 (3 + 4) 2002 (14%) 1704 (14%) 265 (15%) 33 (17%)
 7 (4 + 3) 798 (6%) 658 (5%) 126 (7%) 14 (7%)
 ≥8 551 (4%) 465 (4%) 73 (4%) 13 (7%)
PSA (ng/mL) .004
 <4 3068 (22%) 2646 (22%) 389 (22%) 33 (17%)
 4-9.99 8613 (61%) 7418 (61%) 1062 (61%) 133 (67%)
 ≥10 2371 (17%) 2053 (17%) 285 (16%) 33 (17%)
Pathologic Gleason score .400
 ≤6 8583 (61%) 7471 (62%) 1012 (58%) 100 (50%)
 7 (3 + 4) 3383 (24%) 2882 (24%) 441 (25%) 60 (30%)
 7 (4 + 3) 1168 (8%) 986 (8%) 157 (9%) 25 (13%)
 ≥8 918 (7%) 778 (6%) 126 (7%) 14 (7%)
Pathologic stage .592
 Organ-confined 8968 (64%) 7735 (64%) 1116 (64%) 117 (59%)
 extracapsular extension 4142 (29%) 3569 (29%) 504 (29%) 69 (35%)
 Seminal vesicle/lymph 942 (7%) 813 (7%) 116 (7%) 1 (7%)
 node–positive
Race <.001
 Caucasian 12,675 (90%) 11,005 (91%) 1510 (87%) 160 (80%)
 African American 870 (6%) 679 (6%) 161 (9%) 30 (15%)
 Asian 102 (1%) 82 (<1%) 18 (1%) 2 (1%)
 Other 405 (3%) 351 (3%) 47 (3%) 7 (4%)
BMI (kg/m2) <.001
 <24.9 3386 (24%) 2996 (25%) 364 (21%) 26 (13%)
 25 to <29.9 6517 (46%) 5694 (47%) 742 (43%) 81 (41%)
 ≥30 1919 (14%) 1553 (13%) 319 (18%) 47 (24%)
 Not available 2230 (16%) 1874 (16%) 311 (18%) 45 (23%)